Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilpa Gupta

Showing results (21-30 of 242) with videos related to

Pageof 25
Sort By:
European Urology|July 2, 2022
Time to Rethink Quality of Life Assessment in Patients with Urothelial Cancer in the Current Therapeutic Era?Cristiane Decat Bergerot, Shilpa Gupta
Nature Reviews. Urology|July 8, 2020
NICE's rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?Shilpa Gupta, Ashish M Kamat
Translational Andrology and Urology|January 28, 2016
Milestones for development of tivozanib for kidney cancer therapyRobert Crescentini, Shilpa Gupta, Mayer Fishman
Plos One|September 4, 2020
High-speed imaging of ESCRT recruitment and dynamics during HIV virus like particle buddingShilpa Gupta, Josh Bromley, Saveez Saffarian
Viruses|September 19, 2020
Abrogating ALIX Interactions Results in Stuttering of the ESCRT MachineryShilpa Gupta, Mourad Bendjennat, Saveez Saffarian
European Urology Focus|December 7, 2025
Exciting Times in Urological Oncology: Rapid Advances and Greater Complexity Are Changing Practice and Improving OutcomesShilpa Gupta, James W F Catto
Contemporary Clinical Dentistry|November 25, 2011
Evaluation of the nasolabial angle in the Indian populationVinay Dua, Shilpa Gupta, Chanjyot Singh
Cancer Control : Journal of the Moffitt Cancer Center|December 21, 2013
Epidermal growth factor receptor inhibitors: coming of ageAmit Mahipal, Nishi Kothari, Shilpa Gupta
Oncotargets and Therapy|July 28, 2011
Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatmentsShilpa Gupta, Estrella Carballido, Mayer Fishman
Kidney Cancer (Clifton, Va.)|March 3, 2025
Papillary Renal Cell Carcinoma: Current Evidence and Future DirectionsAlbert Jang, Charbel S Hobeika, Shilpa Gupta
Pageof 25

Showing results (21-30 of 242) with videos related to

Sort By:
Pageof 25
European Urology|July 2, 2022
Time to Rethink Quality of Life Assessment in Patients with Urothelial Cancer in the Current Therapeutic Era?Cristiane Decat Bergerot, Shilpa Gupta
Nature Reviews. Urology|July 8, 2020
NICE's rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?Shilpa Gupta, Ashish M Kamat
Translational Andrology and Urology|January 28, 2016
Milestones for development of tivozanib for kidney cancer therapyRobert Crescentini, Shilpa Gupta, Mayer Fishman
Plos One|September 4, 2020
High-speed imaging of ESCRT recruitment and dynamics during HIV virus like particle buddingShilpa Gupta, Josh Bromley, Saveez Saffarian
Viruses|September 19, 2020
Abrogating ALIX Interactions Results in Stuttering of the ESCRT MachineryShilpa Gupta, Mourad Bendjennat, Saveez Saffarian
European Urology Focus|December 7, 2025
Exciting Times in Urological Oncology: Rapid Advances and Greater Complexity Are Changing Practice and Improving OutcomesShilpa Gupta, James W F Catto
Contemporary Clinical Dentistry|November 25, 2011
Evaluation of the nasolabial angle in the Indian populationVinay Dua, Shilpa Gupta, Chanjyot Singh
Cancer Control : Journal of the Moffitt Cancer Center|December 21, 2013
Epidermal growth factor receptor inhibitors: coming of ageAmit Mahipal, Nishi Kothari, Shilpa Gupta
Oncotargets and Therapy|July 28, 2011
Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatmentsShilpa Gupta, Estrella Carballido, Mayer Fishman
Kidney Cancer (Clifton, Va.)|March 3, 2025
Papillary Renal Cell Carcinoma: Current Evidence and Future DirectionsAlbert Jang, Charbel S Hobeika, Shilpa Gupta
Pageof 25